MDMA with Exposure Therapy for PTSD
Treatments studied
Part of Mental health clinical trials.
This trial tests whether MDMA (the drug in ecstasy) combined with a type of talk therapy called massed exposure therapy can help treat PTSD. It may be an option if standard treatments haven't worked well enough.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a current diagnosis of PTSD confirmed by a clinician.
- You can speak and read English well enough to complete study assessments.
- You are willing to have your study visits recorded (video and audio).
- You agree to use effective birth control if you could become pregnant.
- You are willing to avoid certain medications and follow lifestyle changes (like fasting before the medicine session).
- You are not currently participating in any other interventional clinical trials.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether combining MDMA with talk therapy can help people with post-traumatic stress disorder (PTSD) from war experiences. It involves both individual and group therapy sessions, and the medication is given during some sessions.
This study tests whether MDMA (a drug that can help people feel safe and open during therapy) combined with talk therapy can reduce PTSD symptoms in active-duty service members, National Guard, and Reserve members. If you are struggling with PTSD that has lasted at least 6 months, this trial may offer a new treatment option.
This study tests whether MDMA (a medication) combined with therapy can help veterans with post-traumatic stress disorder (PTSD). MDMA may help people process difficult memories and emotions more effectively during therapy sessions.
This Phase 2 trial tests whether therapy assisted by MDMA can reduce symptoms of moderate to severe post-traumatic stress disorder (PTSD) in eligible veterans. It includes supervised therapy sessions and extra study visits with video recording to track changes over time.
This study tests whether MDMA, combined with a type of talk therapy called CBCT (cognitive behavioral conjoint therapy), is more effective than CBCT alone for treating PTSD. You and a close partner will both participate in therapy sessions and take MDMA together.
This study tests whether a medication called MDMA, when combined with therapy sessions, can help reduce stress and trauma symptoms in healthcare workers and first responders. The goal is to see if this treatment improves their well-being and ability to cope with job-related stress.
Hear when a new PTSD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.